Assertio (NASDAQ: ASRT)
Assertio Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Assertio Company Info
Assertio Holdings, Inc. engages in the provision of commercial pharmaceutical products. Its commercial portfolio of branded products focuses on the following areas: neurology, hospital, and pain and inflammation. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.
News & Analysis
Why Depomed Inc.'s Shares Soared 23.2% Higher
The company rewarded investors with good news today.
Here's Why Depomed Inc Fell as Much as 13.8% Today
The company announced full-year 2017 earnings yesterday after the market closed.
Why Depomed Inc.'s Shares Are Rallying 10% Today
The company hopes a restructuring of its business can help it get back on its feet.
Here's Why Collegium Pharmaceutical Rose as Much as 23.5% Today
The company is acquiring a new drug with over $200 million in annual sales, but it won't be cheap.
Why Avis Budget Group, Depomed, and Tenet Healthcare Slumped Today
These stocks helped drag the market lower. Find out why.
Why Depomed Inc. Stock Spiked Today
The drugmaker is reportedly drawing buyout interest from KKR & Co., upping the possibility that a sale is finally imminent.
Why Depomed Inc. Got Wacked Today
It's painful for shareholders when M&A hopes die.
Why Depomed Inc.'s Shares Are Crashing 18.9% Today
Disappointing third quarter financials is causing investors to sell off shares.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.